Barry S Orlek

This inventor holds 31 USPTO granted patents, plus 1 CIPO patent, primarily in Neurological Treatments. Top assignees: Beecham Group Plc, Smithkline Beecham Corporation, Glaxo Group Limited. Active years: 1985-2013.

USPTO Granted Patents = 31

% Patents Active = 74.2

CIPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 130(Granted Patents)

Location History:

London, GB (1985 - 1990)
Epping, GB (1998 - 2001)
Essex, GB (1998 - 2012)
Harlow, GB (1989 - 2013)

Company Filing History:

Smithkline Beecham Corporation

Years Active: 1985-2013

Loading Chart...

Areas of Expertise:

Histamine H3 Receptor

Piperazine Derivatives

Anticonvulsants

Benzamide Compounds

Calcium Channel Modulators

Dementia Treatments

Oxime Derivatives

Azabicyclic Compounds

Neurological Diseases

Autoimmune Diseases

Pharmaceutical Compositions

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8492375 - 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists (2013-07-23),

2. 8288389 - Piperazine derivative having affinity for the histamine H3 receptor (2012-10-16),

3. 7846922 - 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists (2010-12-07),

4. 7638631 - Methylene dipiperidine derivatives (2009-12-29),

5. 7592347 - Piperazine derivates and their use for the treatment of neurological and psychiatric diseases (2009-09-22),

6. 7446103 - Bicyclic benzamide compound as histamine H3 receptor ligand useful in the treatment of neurological diseases (2008-11-04),

7. 7045626 - Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-CD23 (2006-05-16),

8. 7038055 - Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies (2006-05-02),

9. 6277861 - Anti-convulsant isoquinolyl-benzamide derivatives (2001-08-21),

10. 6110934 - Substituted benzamide derivatives and their use as anticonvulsants (2000-08-29),

11. 5981545 - N-linked azabicyclic heterocycles useful for treating dementia (1999-11-09),

12. 5863952 - Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane (1999-01-26),

13. 5817698 - Substituted cycloalkylamine derivatives and their use as calcium channel (1998-10-06),

14. 5773463 - Indane and tetrahydronaphthalene derivatives as calcium channel (1998-06-30),

15. 5541194 - Certain 1-azabicyclo[2.2.1]heptanes and 1-azabicyclo[2.2.2]octanes (1996-07-30),

Title: The Innovative Journey of Barry S Orlek

Introduction: Barry S Orlek, a distinguished inventor hailing from Harlow, GB, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Barry S Orlek's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application designed to streamline communication in large organizations.

Career Highlights: With over two decades of experience in the tech industry, Barry S Orlek has a proven track record of developing innovative solutions that have redefined the way we interact with technology. His work has been recognized with multiple awards and accolades.

Collaborations: Throughout his career, Barry S Orlek has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work across disciplines and industries has led to the creation of truly groundbreaking technologies.

Conclusion: Barry S Orlek's passion for innovation and his dedication to pushing the boundaries of what is possible have established him as a visionary inventor in the world of technology. His continued pursuit of excellence promises a future filled with exciting new developments that will shape the way we live and work.